These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 7598782)
41. Skin allograft and vascularized composite allograft: potential for long-term efficacy in the context of lymphatic modulation. Rinkinen J; Selley R; Agarwal S; Loder S; Levi B J Burn Care Res; 2014; 35(5):355-61. PubMed ID: 25051523 [TBL] [Abstract][Full Text] [Related]
42. The enhancement of wound healing with human skin allograft. Spence RJ; Wong L Surg Clin North Am; 1997 Jun; 77(3):731-45. PubMed ID: 9194889 [TBL] [Abstract][Full Text] [Related]
43. [The intermingled transplantation used in severe burn patients after eschar excision]. Liao ZJ Zhonghua Shao Shang Za Zhi; 2008 Oct; 24(5):340-2. PubMed ID: 19103011 [TBL] [Abstract][Full Text] [Related]
44. [Biological and molecular biology aspects of burn therapy]. Vogt PM; Hebebrand D; Hussmann J; Steinau HU Chirurg; 1995 Apr; 66(4):251-9. PubMed ID: 7634932 [TBL] [Abstract][Full Text] [Related]
45. The banking and clinical use of human skin allograft in trauma patients: the banking of allograft skin in Maryland. Spence RJ Md Med J; 1986 Feb; 35(2):117-9. PubMed ID: 3512948 [No Abstract] [Full Text] [Related]
46. Closure of the excised burn wound: temporary skin substitutes. Saffle JR Clin Plast Surg; 2009 Oct; 36(4):627-41. PubMed ID: 19793557 [TBL] [Abstract][Full Text] [Related]
47. The use of homograft compared to topical antimicrobial therapy in the treatment of second-degree burns of more than 40% total body surface area. Naoum JJ; Roehl KR; Wolf SE; Herndon DN Burns; 2004 Sep; 30(6):548-51. PubMed ID: 15302419 [TBL] [Abstract][Full Text] [Related]
48. [Use of preserved homograft for covering burn injuries]. Kósa J; Nagy L; Csönge L; Horváth O Magy Traumatol Ortop Kezseb Plasztikai Seb; 1993; 36(1):37-41. PubMed ID: 8343832 [TBL] [Abstract][Full Text] [Related]
49. [Basic principles of skin transplantation in burns and use of lyophilized skin transplants]. Herrmann L; Rogowitz L; Ullrich H Zentralbl Chir; 1965; 90(26):1129-34. PubMed ID: 5327498 [No Abstract] [Full Text] [Related]
50. Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate. Tran HS; Malli D; Chrzanowski FA; Puc MM; Matthews MS; Hewitt CW J Surg Res; 1999 May; 83(2):136-40. PubMed ID: 10329107 [TBL] [Abstract][Full Text] [Related]
51. Porcine xenografts vs. (cryopreserved) allografts in the management of partial thickness burns: is there a clinical difference? Hermans MH Burns; 2014 May; 40(3):408-15. PubMed ID: 24018214 [TBL] [Abstract][Full Text] [Related]
52. Homograft skin banking--current practices and future trends. Fielding GA; Pegg SP Aust N Z J Surg; 1988 Feb; 58(2):153-6. PubMed ID: 3269208 [TBL] [Abstract][Full Text] [Related]
53. [Organ culture of human skin using dermis from cadavers]. Carles D; Bodkier M; Verdier MM; Neretti J; Richir C C R Seances Soc Biol Fil; 1978; 172(5):891-3. PubMed ID: 157202 [TBL] [Abstract][Full Text] [Related]
55. Successful Treatment of Lower Limb Burn Wounds With Long-Term Survived Human Skin Allograft in an Immunosuppressed Patient: A Case Report. Chang CK; Bartkova J; Liao YS; Tzeng YS Int J Low Extrem Wounds; 2021 Jun; 20(2):167-171. PubMed ID: 32037916 [TBL] [Abstract][Full Text] [Related]
56. Current trends in the use of allograft skin for patients with burns and reflections on the future of skin banking in the United States. Greenleaf G; Hansbrough JF J Burn Care Rehabil; 1994; 15(5):428-31. PubMed ID: 7995816 [TBL] [Abstract][Full Text] [Related]